ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 176 filers reported holding ANTARES PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,101,000 | +116.7% | 268,478 | +88.9% | 0.07% | +14.3% |
Q4 2021 | $508,000 | +4.5% | 142,164 | +6.5% | 0.06% | -3.1% |
Q3 2021 | $486,000 | -10.0% | 133,484 | +7.7% | 0.06% | -64.3% |
Q2 2021 | $540,000 | -11.0% | 123,966 | -16.0% | 0.18% | -6.2% |
Q1 2021 | $607,000 | +5.0% | 147,616 | +1.9% | 0.19% | +17.6% |
Q4 2020 | $578,000 | +1129.8% | 144,876 | +733.4% | 0.16% | +1000.0% |
Q3 2020 | $47,000 | -39.0% | 17,383 | -37.9% | 0.02% | -42.3% |
Q2 2020 | $77,000 | +16.7% | 27,971 | 0.0% | 0.03% | -7.1% |
Q1 2020 | $66,000 | – | 27,971 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |